Kelly K Hunt Selected Research

Kelly K Hunt Research Topics

Disease

241	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2002
200	Neoplasms (Cancer) 06/2022 - 01/2002
37	Neoplasm Metastasis (Metastasis) 01/2019 - 05/2002
23	Sarcoma (Soft Tissue Sarcoma) 10/2022 - 09/2002
21	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2019 - 11/2002
17	Pathologic Complete Response 10/2021 - 01/2002
14	Carcinoma (Carcinomatosis) 07/2020 - 05/2002
12	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2022 - 01/2016
11	Triple Negative Breast Neoplasms 04/2021 - 10/2011
9	Disease Progression 01/2022 - 08/2003
9	Melanoma (Melanoma, Malignant) 09/2018 - 04/2002
9	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2014 - 12/2003
8	Lobular Carcinoma 01/2021 - 10/2006
8	Leiomyosarcoma 01/2017 - 11/2005
7	Lung Neoplasms (Lung Cancer) 01/2018 - 04/2002
7	Necrosis 12/2013 - 05/2004
6	Lymphoma (Lymphomas) 12/2021 - 11/2004
6	Lymphatic Metastasis 04/2016 - 04/2008
5	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 01/2016
5	Margins of Excision 12/2018 - 02/2003
5	Inflammatory Breast Neoplasms 02/2017 - 07/2007
5	Carcinogenesis 01/2016 - 11/2004
4	Lymphedema (Milroy Disease) 02/2019 - 10/2006
4	Residual Neoplasm 01/2018 - 10/2006
4	Infections 08/2014 - 08/2005
4	Genomic Instability 01/2011 - 11/2006
4	Ductal Carcinoma 06/2009 - 10/2006
3	Liposarcoma 01/2022 - 04/2015
3	Hemangiosarcoma (Angiosarcoma) 01/2021 - 12/2005
3	Postoperative Pain 03/2020 - 09/2009
3	Neoplasm Micrometastasis 01/2018 - 09/2003
3	Lymphadenopathy 12/2017 - 02/2011
3	Unilateral Breast Neoplasms 03/2011 - 01/2005
3	Anaphylaxis (Anaphylactic Shock) 04/2006 - 02/2004

Drug/Important Bio-Agent (IBA)

38	Estrogen ReceptorsIBA 01/2019 - 10/2003
22	Proteins (Proteins, Gene)FDA Link 01/2016 - 12/2002
19	Cyclin EIBA 05/2021 - 08/2005
18	Biomarkers (Surrogate Marker)IBA 05/2021 - 12/2002
17	Hormones (Hormone)IBA 01/2022 - 08/2005
16	Progesterone Receptors (Progesterone Receptor)IBA 08/2018 - 04/2002
15	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 01/2002
13	Biological ProductsIBA 08/2018 - 11/2004
10	Trastuzumab (Herceptin)FDA Link 12/2013 - 08/2004
8	Biological FactorsIBA 07/2020 - 07/2016
8	Paclitaxel (Taxol)FDA LinkGeneric 12/2013 - 04/2002
7	Phosphotransferases (Kinase)IBA 04/2021 - 06/2004
7	AnthracyclinesIBA 01/2021 - 08/2002
7	Coloring Agents (Dyes)IBA 12/2020 - 02/2004
7	Protein Isoforms (Isoforms)IBA 10/2018 - 06/2004
7	Estrogens (Estrogen)FDA Link 08/2018 - 04/2002
7	Fluorouracil (Carac)FDA LinkGeneric 12/2013 - 06/2005
7	Imatinib Mesylate (Gleevec)FDA Link 01/2012 - 12/2003
6	Capsules (Microcapsules)IBA 12/2021 - 01/2016
6	human ERBB2 proteinIBA 10/2017 - 06/2005
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2013 - 06/2005
6	eIF-2 Kinase (eIF 2 Kinase)IBA 08/2008 - 04/2002
6	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 04/2006 - 01/2003
6	Double-Stranded RNA (RNA, Double Stranded)IBA 11/2005 - 04/2002
5	palbociclibIBA 01/2022 - 01/2017
5	Pharmaceutical PreparationsIBA 01/2016 - 04/2003
5	ElafinIBA 06/2015 - 12/2007
5	Tamoxifen FDA LinkGeneric 08/2010 - 01/2002
5	CytokinesIBA 02/2007 - 05/2002
4	Taxoids (Taxanes)IBA 01/2021 - 10/2008
4	taxaneIBA 01/2021 - 12/2009
4	Phenobarbital (Luminal)FDA Link 01/2020 - 12/2010
4	Cytostatic AgentsIBA 01/2020 - 09/2010
4	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 11/2006
4	Epirubicin (Ellence)FDA LinkGeneric 12/2013 - 06/2005
4	ParaffinIBA 07/2013 - 01/2004
4	E2F1 Transcription FactorIBA 03/2010 - 04/2003
3	Aromatase InhibitorsIBA 01/2022 - 02/2010
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019 - 01/2017
3	EnzymesIBA 01/2018 - 10/2009
3	ErbB Receptors (EGF Receptor)IBA 10/2016 - 06/2005
3	RoscovitineIBA 01/2012 - 10/2008
3	Eosine Yellowish-(YS) (Eosin)IBA 07/2011 - 04/2005
3	Hematoxylin (Haematoxylon)IBA 07/2011 - 04/2005
3	Complement System Proteins (Complement)IBA 01/2011 - 02/2007
3	Interleukin-10 (Interleukin 10)IBA 02/2007 - 01/2004
3	interleukin-24 (ST16)IBA 02/2007 - 08/2003
3	LuciferasesIBA 08/2005 - 04/2003

Therapy/Procedure

109	Therapeutics 06/2022 - 01/2002
81	Neoadjuvant Therapy 03/2022 - 01/2002
59	Segmental Mastectomy (Lumpectomy) 01/2022 - 03/2002
57	Radiotherapy 01/2022 - 04/2002
54	Drug Therapy (Chemotherapy) 10/2021 - 04/2002
46	Mastectomy (Mammectomy) 01/2022 - 01/2002
30	Lymph Node Excision (Lymph Node Dissection) 10/2022 - 01/2003
12	Breast Implants (Breast Implant) 09/2022 - 01/2016
11	Mammaplasty (Breast Reconstruction) 01/2019 - 05/2002
10	Adjuvant Chemotherapy 01/2021 - 07/2002
6	Contraindications 01/2022 - 01/2006
6	Aftercare (After-Treatment) 04/2021 - 01/2007
6	Surgical Instruments (Clip) 01/2019 - 12/2007
6	Brachytherapy 01/2019 - 05/2011
6	Prophylactic Mastectomy 01/2018 - 10/2006
4	Simple Mastectomy 03/2011 - 03/2004
3	Operative Surgical Procedures 10/2016 - 03/2003
3	Catheters 08/2014 - 02/2004